Immuno-Oncology

26/09/2018 - 27/09/2018 London

Immuno-Oncology
Main Conference: 26 – 27 September 2018
Pre-Conference Workshops: 25 September 2018
Copthorne Tara Hotel, London, UK
www.immuno-oncology-conference.com

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies.

SMi’s Immuno-Oncology Conference will focus on a few key areas of the field with representation of the whole industry, under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

 

At the SMi’s Immuno-Oncology Conference participants will get:

Agenda – Valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for attendees. 15+ engaging presentations/case studies/keynote addresses, including:

  • Targeting immune checkpoints with Humabody VH therapeutics
  • Recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
  • Tumour mutation burden and the potential of its use as an indication of treatment choice
  • Unwanted immunogenicity and functionality testing of immuno-oncology drugs
  • New techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology

 

Speakers – Top representation of industry leaders. 15+ leading experts in Immuno-Oncology field, including

  • James Legg, Vice President R&D, Crescendo Biologics
  • Andrew Exley, Medical Assessor, MHRA
  • Harry Smith, Medical Scientist, Gilead Sciences
  • Grace Macaulay, Global Safety Physician Patient Safety Oncology, MedImmune
  • David Giljohan, CEO, Exicure
  • Kandeepan Ganeshalingam, Executive Director, Oncology Therapeutic Area Head, European Clinical Development, MSD
  • Rochana Wickramasinghe, Director of Oncology Evaluation, AstraZeneca

 

Workshops – Carefully selected topics for further on-sight training. 2 pre-conference workshops to provide in-depth knowledge on specific topics:

  • Strategic Competitive Intelligence in the Immuno-Oncology space – hosted by LucidQuest Ventures
  • Could the Microbiome boost Cancer Immuno-Therapy – hosted by ImmuneBiotech and Lund University

 

Networking – it is at the forefront of SMi events. 5+ hours of pure networking guaranteed. Follow event updates to be in the know about who will be joining the conversation.

 

To view detailed information about event programme, speaker line-up and workshop agenda visit website

 

Twitter – @SMIpharm & #immunooncologysmi

LinkedIn – SMi Pharma

 

CONTACT:

+44 (0)20 7827 6000

ldurneva@smi-online.co.uk